秦琼
副主任药师、讲师
苏州大学附属第一医院药学部
E-mail：q-q2456@163.com
个人简介:
秦琼是苏州大学附属第一医院药学部心脏大血管外科临床药师。2018年赴中山大学附属第一医院完成抗凝治疗临床药师规范化培训，2022年赴上海长海医院完成临床药师师资培训。现为国家临床药师培训抗凝治疗专业带教师资，中国药科大学治疗药物管理(MTM)认证药师。重点围绕全程化药学服务、抗凝药物合理使用等方面开展工作。主要研究方向：临床药学与个体化治疗；肠道菌群与中医药理论。目前担任中国民族医药学会方药量效研究分会常务理事，中国医药质量管理协会医疗质量创优工作委员会委员，苏州市医学会心身医学分会心身疾病药物治疗学组委员，苏州市药学会人文药学专委会委员兼秘书，苏州市中西医结合学会慢病防治药学专委会青委兼秘书。主持省、市厅级课题9项。获得江苏省医学新技术引进奖二等奖1项，江苏省药学会医院药学科研项目二等奖1项，软件著作权1项。以第一或通讯作者发表 SCI 4 篇（最高 IF=15.3）及北图核心期刊13篇。参编人卫版著作4部。
研究方向:
1. 临床药学与个体化治疗
2. 抗凝药物治疗药物监测
3. 中药防治炎症免疫性疾病的效应和机制
4. 肠道菌群与心脏损伤的关系研究
代表性论文（*代表通讯作者）:
1. Ding Y, Xue L, Qin Q, Huang H, Chen Y, Shen H, Hu Y, Chen Y, Miao L, Shen Z. Exploring the effects of renal and cardiac functions on the pharmacokinetics of vancomycin in patients undergoing cardiac surgery: a population pharmacokinetic analysis. Int J Clin Pharm. Published online January 21, 2026. doi:10.1007/s11096-025-02077-w
2. Xue L, Ma G, Holford N, Qin Q, Ding Y, Hannam JA, Ding X, Fan H, Ji Z, Yang B, Shen H, Shen Z, Miao L. A Randomized Trial Comparing Standard of Care to Bayesian Warfarin Dose Individualization. Clin Pharmacol Ther, 2024, 115(6):1316-1325.
3. Ling Xue, Shan He, Rajeev K Singla, Qiong Qin, Yinglong Ding, Linsheng Liu,Xiaoliang Ding, Harbil Bediaga-Bañeres, Sonia Arrasate,Aliuska Durado-Sanchez, Yuzhen Zhang, Zhenya Shen, Bairong Shen, Liyan Miao, Humberto González-Díaz. Machine learning guided prediction of warfarin blood levels for personalized medicine based on clinical longitudinal data from cardiac surgery patients: a prospective observational study. Int J Surg,2024,110(10):6528-6540.
4. Chunge Zhang, Qi Wu, Yinhua Gong, Qiong Qin, Qiang Han, Zongqi Cheng, Zhaowei Yan. Biomimetic exosomal vesicles loaded with siRNA improves antitumor immune responses by inhibiting the secretion of tumor-derived exosome PD-L1. Int Immunopharmacol. 2024;129:111659.
5. Xue L, Ding Y, Qin Q, Liu L, Ding X, Zhou Y, Liu K, Singla RK, Shen K, Din AU, Zhang Y, Shen Z, Shen B, Miao L. Assessment of the impact of intravenous antibiotics treatment on gut microbiota in patients: Clinical data from pre-and post-cardiac surgery. Front Cell Infect. Microbiol, 2023, 12:1043971.
6. Xue L, Singla RK, Qin Q, Ding Y, Liu L, Ding X, Qu W, Huang C, Shen Z, Shen B, Miao L. Exploring the complex relationship between vitamin K, gut microbiota, and warfarin variability in cardiac surgery patients.Int J Surg, 2023,109(12): 3861-3871.
7. Xie C, Lin J, Qin Q, Zhu J. Efficacy and Safety of Ticagrelor in East Asian Patients with Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials. Anatol J Cardiol. 2022;26(6):434-441.
8. Wanqing Wang, Tao Xu, Qiong Qin, Liyan Miao, Jian an Bao, and Rong Chen. Effect of a Multidimensional Pharmaceutical Care Intervention on Inhalation Technique in Patients with Asthma and COPD. Canadian Respiratory Journal, 2020,2020:8572636.